Novo Nordisk has officially launched its groundbreaking weight-loss drug, Wegovy, in China, marking a significant step in addressing obesity in the world’s most populous country. The drug’s approval by Chinese
Novo Nordisk has officially launched its groundbreaking weight-loss drug, Wegovy, in China, marking a significant step in addressing obesity in the world’s most populous country. The drug’s approval by Chinese